Search results

| IUPAC_name = (11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione ...BW. Relapse management in multiple sclerosis. Neurologist. 2009 Jan;15(1):1-5. Review. PMID 19131851</ref>, [[cluster headaches]], [[vasculitis]], [[ac

| IUPAC_name = 1-cyclopropyl- 6-fluoro- 4-oxo- 7-piperazin- 1-yl- quinoline- 3-carboxylic acid ...-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)

...AC_name = (±)-''N''-methyl-3-phenyl-3-[4- (trifluoromethyl)phenoxy]propan-1-amine | imagename = 1 : 1 mixture (racemate)<br />

| imagename = 1 : 1 mixture (racemate)<br/> ...1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)

| C = 12 |H = 11 |Cl = 1 |N = 2 |O = 5 |S = 1 ...development, the &alpha;₆&beta;₂&gamma;₂ receptor increases in expression in cerebellar granule neurons, corresponding to inc

|IUPACName=4-(2-aminoethyl)benzene-1,2-diol | InChI = 1/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2

...26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 | smiles = O=C4\C=C2/[C@]([C@H]1[C@@H](O)C[C@@]3([C@@](O)(C(=O)CO)CC[C@H]3[C@@H]1CC2)C)(C)CC4

|IUPAC_name = ''(R)''-4-(1-hydroxy-<br />2-(methylamino)ethyl)benzene-1,2-diol | InChI = 1/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1

| InChI = InChI=1/N2O/c1-2-3 | Density = 1.977 g/L (gas)

| C=17|H=19|N=1|O=3 {| bgcolor="#ffffff" border="1" cellpadding="3" cellspacing="0" align="right" width="167px" style="border-

| IUPAC_name = (R*,S*)-2-(methylamino)-1-phenylpropan-1-ol | InChI = 1/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/m0/s1

|IUPAC_name=''7-Chloro- 1,3-dihydro- 3-hydroxy- 1-methyl- 5-phenyl- 1,4-benzodiazepin- 2-one'' |C=16 |H=13 |Cl=1 |N=2 |O=2

...t to it, [[diabetes mellitus|diabetes]] occurs. Glucagon, secreted by the alpha cells of the pancreas, helps the body utilise stored [[glycogen]] or conver ...ly. Mutation of it has resulted in [[Crohn's disease]]. Excessive T-helper 1 responses to resident flora in the gut are controlled by inhibiting the con

| IUPAC_name = 3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydro-1''H''-purine-2,6-dione | elimination_half-life = 0.4 - 0.8 hours (1 - 1.6 hours for active metabolite)

| C=9 | H=9 | Br=1 | F=1 | N=3 ...rinary Medicine A. Physiology, Pathology, Clinical Medicine''. 2007 Feb;54(1):48-50. PMID 17359455</ref><ref>Belda E, Laredo FG, Escobar M, Soler M, Luc

| IUPAC_name = 4-(1-naphthalen- 1-ylethyl)- 1H-imidazole ...atents?id=MLUiAAAAEBAJ&dq=5151526 Fu-Lian Hsu and William P. Ashman. 4-(1-(1-naphthalenyl)ethyl)- 1H- imidazole, method of making and use as an anesthet

...&#x200b;dimethylphenyl)-&#x200b;5,6-&#x200b;dihydro-&#x200b;4''H''-&#x200b;1,3-&#x200b;thiazin-&#x200b;2-&#x200b;amine | C=12 | H=16 | N=2 | S=1

| IUPAC_name = 5-Bromo-''N''-(4,5-dihydro-1''H''-imidazol-2-yl) quinoxalin-6-amine | C=11 | H=10 | Br=1 | N=5

| IUPAC_name = (''S'')-4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole | InChI = 1/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1

-4,5-dihydro-1''H''-imidazole ...ed under many brand names (see below), with the typical adult dose being 0.1% [[w/v]] xylometazoline, and the dose for children under 12 being 0.05%.{{F

...3N3/c1-14-6-8-18(16(3)10-14)20-12-22(5)13-21-19-9-7-15(2)11-17(19)4/h6-13H,1-5H3/b20-12+,21-13+ | CASNo=33089-61-1

| IUPAC_name = [(1S,3S,5S,7S)-7-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenyl-propanoate | InChI = 1/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-1

...b-hydroxy-2-methyl- 3,6-dioxooctahydro-2''H''-oxazolo[3,2-''a''] pyrrolo[2,1-''c'']pyrazin-2-yl) -7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-''fg''] quin ...-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1

| IUPAC_name = (''RS'')-4-[1-(2,3-dimethylphenyl)ethyl]-3''H''-imidazole | imagename = 1 : 1 mixture (racemate)<br />

| IUPAC_name = 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1''H''-imidazole ...ction in reducing swelling when applied to [[mucous membrane]]. It acts on alpha-receptors in the [[arterioles]] of the [[conjunctiva]] to produce constrict

| IUPAC_name = 4-[1-hydroxy-2-(methylamino)ethyl]phenol | C=9|H=13|N=1|O=2

| IUPAC_name = (''R'')-3-[-1-hydroxy-2-(methylamino)ethyl]phenol | C=9 | H=13 | N=1 | O=2 |

| IUPAC_name = 5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinoline | C=10 | H=11 | N=1 | O=2

| IUPAC_name = 3-(4,5-dihydro-1''H''-imidazol-2-ylmethyl)- 2,4-dimethyl-6-tert-butyl-phenol | C=16 | H=24 | N=2 | O=1

...ergic receptor]]s. The alpha-adrenergic receptor has two subclasses α₁ and α₂. Although complete selectivity between receptor agonism is rarely achieved, some agents have partial selectivity.

| IUPAC_name = (''R'')-2-[1-(3'-Nitrobiphenyl-2-yloxy)ethyl]-4,5-dihydro-1''H''-imidazole ..., Vesprini C, Pigini M |title=Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective a

| IUPAC_name = 2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole ...a 2-adrenoceptors |journal=General Pharmacology |volume=24 |issue=1 |pages=1–8 |year=1993 |month=January |pmid=8387042 |doi= |url=}}</ref> It has been

...n AJ |title=Pel-Ebstein fever |journal=N. Engl. J. Med. |volume=333 |issue=1 |pages=66–7 |year=1995 |month=July |pmid=7777006 |doi= 10.1056/NEJM199507 ...ins above normal throughout the day and does not fluctuate more than {{val|1|u=°C}} in 24 hours, ''e.g.'' [[lobar pneumonia]], [[typhoid]], [[urinary t

...r/>Legend: →&nbsp;tumor&nbsp;←, ★&nbsp;central [[pleural effusion]], 1&3&nbsp;lungs, 2&nbsp;spine, 4&nbsp;ribs, 5&nbsp;[[aorta]], 6&nbsp;[[spleen] ...C]] viruses ([[hepatocellular carcinoma]]), [[Human T-cell leukemia virus-1]] (T-cell leukemias), and [[Helicobacter pylori]] ([[gastric carcinoma]]).<

}}Chapter 1</ref>. The key to Bjerrum’s method was the use of the then recently devel ...lume=21|pages=53–77|doi=10.1016/0039-9140(74)80063-9|pmid=18961420|issue=1}}</ref> were developed so that today the determination of stability constan

If the initial concentration of dinitrogen tetroxide is 1 mole per litre, this will decrease by α at equilibrium giving, by stoichio ...1+α. Thus, substituting the mole fractions with actual values in term of alpha and simplifying;

...ub>2</sub>SO₄, Reactant₂=OH^-, Product₁=SO₄^2- and Product₂=H₂O.</ :<math>\alpha A +\beta B ... \rightleftharpoons \sigma S+\tau T ...</math>

...'' (2006) ''Rook's Textbook of Dermatology CD-ROM''. Wiley-Blackwell. ISBN 1-4051-3130-6.</ref> Within the latter type, there are hairs in structures c ...=Dermatology |publisher=Mosby |location=St. Louis |year=2007 |pages= |isbn=1-4160-2999-0 |oclc= |doi= |accessdate=}}</ref>

* [[Hereditary type 1 neuropathy]] * [[Hyperaldosteronism, familial type 1]]

* [[Male pseudohermaphroditism due to 5-alpha-reductase 2 deficiency]] * [[Malignant hyperthermia susceptibility type 1]]

{| class="wikitable sortable" border="1" | AAT <br><small>''see'' [[alpha 1-antitrypsin deficiency]] </small> || ||

Angiotensinogen is an [[Alpha globulin|α-2-globulin]] that is produced constitutively and released into ...id]] peptide (des-Asp) angiotensin I ([[CAS registry number|CAS]]# 9041-90-1).

!Receptor <BR> (↑ = opens. ↓ = closes) <ref name=boron/> <br> <font size=1> On [[vascular smooth muscle cells]] if not otherwise specified ...lar Approaoch |publisher=Elsevier/Saunders |location= |year= |pages= |isbn=1-4160-2328-3 |oclc= |doi=}} Page 479</ref>

!Receptor <br/> (↑ = opens. ↓ = closes) <ref name=boron/> <br> <font size=1> On [[vascular smooth muscle cells]] if not otherwise specified ...lar Approaoch |publisher=Elsevier/Saunders |location= |year= |pages= |isbn=1-4160-2328-3 |oclc= |doi=}} Page 479</ref>

...iac muscle cells]]. Acetylcholine then binds to [[Muscarinic acetylcholine receptor M2|M₂ muscarinic receptors]], causing the decrease in heart rate ...node]] via [[Gi alpha subunit|G_i protein]]-[[G protein-coupled receptor|coupled receptors]] and through modulation of [[muscarinic potassium channe

...the '''nonclassical cannabinoids''' including the [[aminoalkylindole]]s, [[1,5-diarylpyrazoles]], [[quinoline]]s and arylsulphonamides, as well as [[eic {{Main|Cannabinoid receptor}}

...is quite different, acting primarily as [[Mu opioid receptor|mu]]-[[opioid receptor]] agonists. Other active chemicals in kratom include [[raubasine]] (best k ...The subjective effects of kratom use are similar to the effects of opiate receptor agonists such as [[codeine]] or [[hydrocodone]], and will prevent withdrawa

| IUPAC_name = 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-pentyl-benzene-1,3-diol ...)19(21(23)15-18)13-12-17(4)10-8-9-16(2)3/h9,12,14-15,22-23H,5-8,10-11,13H2,1-4H3/b17-12+

...= 4-[(1S,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol ...ar N, Yue TL, Brown AJ, Morrison AD, Douglas SA. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vaso

...thyl-<br />3-pentyl-6a,7,8,10a-tetrahydro-<br />6''H''-benzo[''c'']chromen-1-ol | elimination_half-life = 1.6-59 hours <ref name="pmid12648025"/>, 25-36 hours (orally administered Dro

| SMILES=CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc3ccccc3)NC(=O) ...i/content/short/fj.09-132142v1}}</ref> In addition to the Hp peptides from alpha hemoglobin, a related peptide from beta hemoglobin has been found in mouse

|status_system = IUCN3.1 ...sativa'' L.: A morphological and molecular study]. ''Euphytica'' '''140'''(1-2): 95-106. Retrieved on 25 February 2007</ref> Although monoecious plants

...nd memory | journal = Prog. Neurobiol. | volume = 70 | issue = 1 | pages = 1–32 | year = 2003 | month = May | pmid = 12927332 | doi = 10.1016/S0301-00 ...| year = 2006 | pmid = 16930452 | pmc = 1538601 | doi = 10.1186/1750-1326-1-5 | url = | issn = }}</ref> The amyloid beta region of the protein, located

...AR]] has recently achieved consensus on the best names, '''K_Ca2.1''' (SK1), '''K_Ca2.2''' (SK2) and '''K_Ca2.3''' (SK3).< ...rogen enhanced the ability of [[alpha-1 adrenergic receptor|α1 adrenergic receptor]]s to inhibit K_Ca2.3 activity, increasing cell excitability.<ref

...y inhibiting cAMP-HCN channel signaling in prefrontal cortex. Vol. 129. pp 1-14.</ref> ...known as the alpha2A-adrenoceptor (also known as the [[alpha-2A adrenergic receptor]]) has been shown to improve [[working memory]], or the brain’s capacity

...=|accessdate=}}</ref>&nbsp; Signal transduction starts with a signal to a receptor, and ends with a change in cell function. ...de the cell.&nbsp; The chemical signal binds to the outer portion of the receptor, changing its shape and conveying another signal inside the cell.&nbsp; So

| TCDB = 1.A.9 ...els''' ('''LGICs''') are one type of ionotropic receptor or channel-linked receptor. They are a group of [[transmembrane]] [[ion channel]]s that are opened or

| imagename = 1 : 1 Mixture ([[racemate]])<br /> | C=21 | H=27 | N=1 | O=1

| CASNo = 74-85-1 | InChI=1/C2H4/c1-2/h1-2H2

| CAS_number = 591-81-1 ...inique du gamma hydroxybutyrate de Na | journal = Aggressologie | volume = 1 | page =407 | language = French| pmid = 13758011}}</ref> It quickly found a

...heterodyne. The idea is to reduce the incoming frequency which may be, say 1,500,000 cycles (200 meters), to some suitable super-audible frequency which ...ifferent values are used. For example, the front end might be sensitive to 1&ndash;30&nbsp;MHz, the first half of the radio to 5&nbsp;MHz, and the last